tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mitchell Kapoor, 338 are a BUY (89.42%), 27 are a HOLD (7.14%), 13 are a SELL (3.44%).
Analyst Mitchell Kapoor, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 40.18% that have a potential upside of 57.34% achieved within 90 days.
Mitchell Kapoor’s has documented 722 price targets and ratings displayed on 34 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ORKA, Oruka Therapeutics at 23-Jun-2026.
Analyst best performing recommendations are on KYTX (KYVERNA THERAPEUTICS, COMMON STOCK).
The best stock recommendation documented was for LEGN (LEGEND BIOTECH CORP) at 4/18/2023. The price target of $66 was fulfilled within 3 days with a profit of $13.76 (26.34%) receiving and performance score of 87.8.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Aug-2021
$36
$-0.01 (-0.03%)
$36
3 years 7 months 10 days ago
(28-Nov-2022)
3/3 (100%)
$0.35 (0.98%)
267
Buy Since 10-Aug-2021
$36
$-0.01 (-0.03%)
$35
3 years 7 months 16 days ago
(22-Nov-2022)
3/4 (75%)
$0.4 (1.12%)
204
Buy Since 15-Feb-2022
$36
$-0.01 (-0.03%)
$35
3 years 7 months 16 days ago
(22-Nov-2022)
3/4 (75%)
$0.4 (1.12%)
145
Hold Since 22-Nov-2022
$36
$-0.01 (-0.03%)
3 years 7 months 16 days ago
(22-Nov-2022)
1/1 (100%)
$0.4 (1.12%)
48
Buy Since 28-Oct-2022
$36
$-0.01 (-0.03%)
$25
3 years 7 months 17 days ago
(21-Nov-2022)
2/2 (100%)
$0.41 (1.15%)
37
Which stock is Mitchell Kapoor is most bullish on?
Which stock is Mitchell Kapoor is most reserved on?
What Year was the first public recommendation made by Mitchell Kapoor?
